Pharmapack North America attendees can expect to hear from 22+ experts in their respective fields, and with recent developments will address both the House's Safeguarding America's Pharmaceuticals Act (H.R. 1919) and Senate's Drug Supply Chain Security Act (S. 957).

Drug counterfeiting is the crime of the 21st century, said Ron Guido in an interview with PMP NEWS earlier this year, and to fight it, the pharmaceutical industry must work together.

Guido, who previously served as Vice President of Global Brand Protection & Supply Chain Integrity for Johnson & Johnson and is now consulting, will be participating in the upcoming panel discussion at Pharmapack North America, "Serialization as Part of the Counterfeit Drug Battle and Supply Chain Security."

At Pharmapack, industry leaders will go beyond the regulations on serialization and discuss cost-effective approaches to mitigate threats from counterfeit, misbranded and adulterated drugs.

"The Pharmapack Conferenceoffers abalance of educational content and networkingcovering track and trace, materials, packaging design strategies, patient compliance, sustainability and cost control including targeted presentations, panel discussions and networking luncheons," notes Daphne Allen, Editor of PMP News. "At such a critical time for the pharma industry, this event will offer a number of thought-provoking sessions, addressing key issues of interest to a variety of pharmaceutical professionals."

Experts in pharmaceutical packaging and materials presenting at Pharmapack include:

Thanks to this unique portfolio of publications, each year UBM Canon is able to connect 3,500 suppliers from the medical device industry and over 100,000 professionals involved in the design and production of medical devices.